Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cordonnier

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Haematologica|July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesJan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
Antipneumococcal Seroprotection Years After Vaccination in Allogeneic Hematopoietic Cell Transplant RecipientsChristine Robin, Mathilde Bahuaud, Rabah Redjoul, et al.
The New England Journal of Medicine|September 19, 2019
Maribavir for Preemptive Treatment of Cytomegalovirus ReactivationJohan Maertens, Catherine Cordonnier, Peter Jaksch, et al.
Blood|February 7, 2002
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantationPierre Reusser, Hermann Einsele, John Lee, et al.
BMC Microbiology|January 25, 2007
Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cellsKhaled Khoufache, Olivier Puel, Nicolas Loiseau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2020
Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before RevaccinationChristine Robin, Alice-Andree Mariaggi, Rabah Redjoul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2014
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantationPer Ljungman, Ronald Brand, Jennifer Hoek, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignanciesAlexandre Alanio, Emilie Sitterlé, Martine Liance, et al.
American Journal of Hematology|January 23, 2016
Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administrationBashar Al Dweik, Rabah Redjoul, Sylvie Bastuji-Garin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 9, 2026
Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life SettingNassim Kamar, Fanny Vuotto, Catherine Cordonnier, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Haematologica|July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelinesJan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2019
Antipneumococcal Seroprotection Years After Vaccination in Allogeneic Hematopoietic Cell Transplant RecipientsChristine Robin, Mathilde Bahuaud, Rabah Redjoul, et al.
The New England Journal of Medicine|September 19, 2019
Maribavir for Preemptive Treatment of Cytomegalovirus ReactivationJohan Maertens, Catherine Cordonnier, Peter Jaksch, et al.
Blood|February 7, 2002
Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantationPierre Reusser, Hermann Einsele, John Lee, et al.
BMC Microbiology|January 25, 2007
Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cellsKhaled Khoufache, Olivier Puel, Nicolas Loiseau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2020
Long-Term Immunity to Measles after Allogeneic Hematopoietic Cell Transplantation: Factors Associated with Seroprotection before RevaccinationChristine Robin, Alice-Andree Mariaggi, Rabah Redjoul, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2014
Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantationPer Ljungman, Ronald Brand, Jennifer Hoek, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignanciesAlexandre Alanio, Emilie Sitterlé, Martine Liance, et al.
American Journal of Hematology|January 23, 2016
Profound lymphopenia is associated with a lower risk of hepatic cytolysis during antithymocyte globulin administrationBashar Al Dweik, Rabah Redjoul, Sylvie Bastuji-Garin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 9, 2026
Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life SettingNassim Kamar, Fanny Vuotto, Catherine Cordonnier, et al.
Pageof 15